Skip to content
  1. Estonia /
  2. How we work /
  3. Collaboration

Our giving: organisations

Johnson & Johnson is fully committed to providing high quality products and services to healthcare professionals, patients and their families. Simply put, we always place the needs and well-being of the people we serve first. It is important for us to understand all aspects of patients’ needs. That’s why we engage and collaborate with patient organisations, who play an important role in informing, supporting, and assisting patients. As a company, we learn from this interaction, and that helps us in the development of new treatments and in providing useful information.
JJIM Images/JJMTIM_Photo_PatientComfort_01_9533.jpg
It is our goal to ensure that these relationships and partnerships proceed within a principled framework of mutual respect and learning, integrity, independence, and transparency.

This framework has been described in the “Code Of Practice On Relationships Between The Pharmaceutical Industry And Patient Organisations”, as developed by the European Federation Of Pharmaceutical Industry Associations (EFPIA) in collaboration with pan-European patient organisations.
Our company adheres to these principles. Its key components are the following:
  • The independence of patient organizations, in terms of their political judgment, policies and activities, will be assured.
  • All partnerships between patient organisations and the pharmaceutical industry will be based on mutual respect, with the views and decisions of each partner having equal value.
  • The pharmaceutical industry will not request, nor will patient organisations undertake, the promotion of a particular medicine.
  • The objectives and scope of any partnership will be transparent. Financial and non- financial support provided by the pharmaceutical industry will always be clearly acknowledged.
  • The pharmaceutical industry welcomes broad funding of patient organizations from multiple sources.
In order to facilitate collaboration, Janssen has developed the following:
  • A review process by a multi-disciplinary committee to evaluate requests for funding or collaboration.
  • Disclosure of the funding provided to patient organisations. The purpose of our disclosure of contributions is to demonstrate our ongoing commitment to transparency.
JJIM Images/JJ_Photo_Women hugging_GettyImages_825250080_3Star.jpg
What is the nature of our collaboration with patient organisations?
Janssen may interact with patient groups in the following ways:
  • Support of educational programmes and conferences;
  • Sponsorship of fund-raising events;
  • Contributions to support programmes and services for the patient community and their care-givers;
  • Contributions to support activities to help patients and care-givers advocate better treatment, services and support; and also collaborations to raise awareness about the diseases.

The following types of requests are generally not eligible for contributions:
  • Scholarships to individuals;
  • Direct contributions to individuals;
  • Loans.
Contributions Process Statement

A multi-disciplinary committee reviews all requests. Requests should include the organization's mission statement, tax status, project/event description, description of how the funds will be used, project budget (if applicable) and annual operating budget.
Below you will find an overview of the patient organizations that we support in Estonia

Name of the Patient Organisation

Website

Amount

Date of Contract

Eesti Sclerosis Multiplex’i Ühingute Liit MTÜ

www.smk.ee

5000

12 May 2016


Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

1223

26 Oct 2016


Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

1000

26 Oct 2016


Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

2526.6

26 Oct 2016


Name of the Patient Organisation

Website

Amount

Date of Contract

Eesti HIV-positiivsete Võrgustik

www.ehpv.ee

500

30 Mar 2015


Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

1221

11 May 2015

Name of the Patient Organisation

Website

Amount

Date of Contract

Eesti Leukeemia- ja Lümfoomihaigete Liit

www.leukeemia.ee

961.5

16 Oct 2015

Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

1000

16 Oct 2015

Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Vähiliit

www.cancer.ee

1000

11 Aug 2014

Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

950

5 Sep 2014

Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Eesti Müeloomiliit

www.myeloomiliit.ee

2000

18 Sep 2014

Name of the Patient Organisation

Website

Amount

Date of Contract

MTÜ Peaasjad

www.peaasi.ee

2950

28 Nov 2014

Name of the Patient Organisation

Website

Amount

Date of Contract

Estonian Network of PLWH (EHPV)

www.ehpv.ee

500

1 Aug 2013

Name of the Patient Organisation

Website

Amount

Date of Contract

Estonian Myeloma Society

2000

13 Dec 2013